Yüklüyor......
A Mixed Methods Feasibility Trial of PKCι Inhibition with Auranofin in Asymptomatic Patients with Ovarian Cancer
PURPOSE: This trial was undertaken to 1) determine the feasibility of enrolling asymptomatic ovarian cancer patients with Ca-125 elevation to a trial with the PKCι inhibitor, auranofin, and 2) understand patients’ perceptions of Ca-125 monitoring. METHODS: Asymptomatic ovarian cancer patients with C...
Kaydedildi:
| Yayımlandı: | Oncology |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4536897/ https://ncbi.nlm.nih.gov/pubmed/25502607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000369257 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|